https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
The results of the present study provide potential insights into the treatment of periodontitis. Graphical abstract.PURPOSE Aggressive pituitary adenomas (APAs) and pituitary carcinomas (PCs) are challenging for their invasive nature, resistance to treatment and recurrences. Temozolomide (TMZ) is used with benefit and well-tolerated toxicity profile in APAs and PCs. In most studies patients received ≤ 12 cycles but the best length of treatment is debated since other options after discontinuation are scarce and a second cour
Мне нравится
Комментарий
Перепост
